Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Aortic Angulation: Impact on the Success of TAVR

Original Title: Aortic Angulation Attenuates Procedural Success Following Self-Expandable But Not Balloon-Expandable TAVR.

Reference: Abramowitz Y  et al. JACC Cardiovasc Imaging. 2016 Jul 8. [Epub ahead of print].

 

Impact of Post TAVR Aortic Angulation

The angulation degree between aorta and heart can make precise valve implantation challenging, especially extreme angulation, such as a horizontal aortic root.

As obvious as it may seem, there is limited data on the impact of aortic angulation in TAVR.

The aim of this study was to assess the impact of aortic angulation immediately after transcatheter aortic valve replacement (TAVR).

The study included 582 patients undergoing TAVR that had prior procedure CT scans available for aortic angulation evaluation.

End points were considered according to the Valve Academic Research Consortium-2 definitions.

Mean aortic angulation was 47.3 ± 8.7°, and patients were divided in two groups: <48° or ≥48° angulation.

In 480 patients receiving balloon expandable valves, the aorta did not influence acute periprocedural success or short term clinical outcomes.

On the contrary, in 102 patients receiving self-expandable valves, increased aortic angulation attenuated acute periprocedural success (area under the curve: 0.73; CI 95% 0.61 to 0.85; p = 0.008).

The numerical cutoff for aortic angulation with the highest sum of sensitivity and specificity for device success was in fact ≥48° (sensitivity 85%, specificity 61%).

Patients with ≥48 angulation receiving self-expandable valves often needed a second valve and post dilation, had longer fluoroscopy time and increased device embolization and mild or greater than mild paravalvular regurgitation.

Mortality at 30 days was not influenced by device angulation.

 

Conclusion

Increased aortic root angulation can have a negative impact in acute periprocedural success in patients receiving self-expandable aortic valves but no in patients receiving balloon expandable valves.

 

Editorial Comment

Future studies with new devices should include aortic angulation as a factor to assess. New self-expandable repositionable and retrievable valves could solve this problem: during release (when presenting valve waist at annulus level) it is possible to push the whole system so that it “copies” the angulation between aorta and heart and to complete a practically horizontal release.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI

With the expansion of TAVI to younger and lower surgical risk patients, bioprosthetic valve degeneration and the need for repeat interventions are expected to...

Percutaneous Closure of Patent Foramen Ovale in Patients Over 60 Years Old With Cryptogenic Stroke: A Safe and Effective Strategy?

Cryptogenic stroke accounts for up to one-third of all ischemic strokes and remains strongly associated with the presence of a patent foramen ovale (PFO),...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...